Previous 10 | Next 10 |
2023-08-10 22:49:14 ET Trevi Therapeutics, Inc. (TRVI) Q2 2023 Earnings Conference Call August 10, 2023, 04:30 PM ET Company Participants Jennifer Good - President and Chief Executive Officer Lisa Delfini - Chief Financial Officer Conference Call Participants ...
2023-08-10 17:48:49 ET Trevi Therapeutics press release ( NASDAQ: TRVI ): Q2 GAAP EPS of -$0.07 beats by $0.02 . The Company ended the second quarter of 2023 with $94.2 million in cash, cash equivalents and marketable securities. For further details see: Trev...
Trevi Therapeutics Announces Second Quarter 2023 Financial Results and Provides Business Update PR Newswire Plans to initiate three clinical studies in chronic cough indications for later this year remain on track Data from Phase 2 CANAL trial of chronic cough in patie...
Trevi Therapeutics to Report Q2 2023 Financial Results and Provide a Corporate Update on August 10, 2023 PR Newswire Conference call and webcast to be held at 4:30 p.m. EDT NEW HAVEN, Conn. , Aug. 3, 2023 /PRNewswire/ -- Trevi Therapeutics, Inc. (...
Trevi Therapeutics to Participate in Upcoming August Events PR Newswire NEW HAVEN, Conn. , Aug. 1, 2023 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ ...
Trevi Therapeutics to Participate in Upcoming July Investor Events PR Newswire NEW HAVEN, Conn. , July 6, 2023 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio...
2023-06-28 08:20:24 ET OPKO Health ( OPK ) +20% a pproves Pfizer’s NGENLa, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency. Baosheng Media Group ( BAOS ) +15% . Xponential Fitness ( XPOF ) +15% plunges amid shor...
2023-06-13 04:32:53 ET Summary Ole Andreas Halvorsen's 13F stock portfolio value increased to $21.31B in Q1 2023, with Visa, McKesson, UnitedHealth, Elevance Health, and General Electric as the largest holdings. New stakes were established in Lululemon Athletica, Sherwin-Williams,...
Trevi Therapeutics to Participate in Upcoming June Conferences PR Newswire Dr. Toby Maher will be presenting data results from the Phase 2 CANAL trial in IPF chronic cough at American Cough Conference NEW HAVEN, Conn. , May 30, 2023 /PRNewswire/ -- ...
2023-05-22 17:30:42 ET Gainers: Movella Holdings ( MVLA ) +14% . Trevi Therapeutics ( TRVI ) +5% . QUALCOMM ( QCOM ) +5% . Galera Therapeutics ( GRTX ) +4% . LivePerson ( LPSN ) +4% . Losers: Guardant Health (...
News, Short Squeeze, Breakout and More Instantly...
Trevi Therapeutics Inc. Company Name:
TRVI Stock Symbol:
NYSE Market:
Trevi Therapeutics Inc. Website:
Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events PR Newswire Two abstracts accepted for oral presentation at the 13 th London International Cough Symposium NEW HAVEN, Conn. , July 2, 2024 /PRNewswire/ -- Trevi Therapeutic...
Trevi Therapeutics to Participate in Upcoming Conferences PR Newswire NEW HAVEN, Conn. , May 9, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™...
Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates PR Newswire Reaffirms guidance for the Phase 2a RIVER trial in refractory chronic cough and Human Abuse Potential (HAP) Study with topline data for each expected in the second half of...